Skip to main content
. 2020 Apr 3;10:431. doi: 10.3389/fonc.2020.00431

Table 4.

Changes of ER, PR, and HER2 status in primary lesions and brain metastases of breast cancer.

Pos–neg (%) Neg–pos (%) Total (%)
ER (n = 27) 1 (3.7) 2 (7.4) 3 (11.1)
PR (n = 27) 5 (18.5) 3 (11.1) 8 (29.6)
HER2 (n = 27) 1 (3.7) 0 (0) 1 (3.7)

Pos, positive; Neg, negative.